ENTITY

Shield Therapeutics (STX LN)

47
Analysis
Health Care • United Kingdom
Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on pharmaceuticals for unmet medical needs. Its primary product, Accrufer/Feraccru (ferric maltol), is an oral therapy for iron deficiency with or without anemia. The company was founded in 2008 and is headquartered in Gateshead, United Kingdom.
more
Company Event • 01 Sep 2026 21:15 • Latest

Status update

Company Event • 20 Aug 2026 14:00 • Upcoming
Add To Calendar

H1 2026

Company Event • 30 Jul 2026 21:15

Q2 2026 TU

Company Event • 05 May 2026 21:15

Q1 2026 TU

Company Event • 01 May 2026 14:00 • Upcoming
Add To Calendar

Trading update

x